| MiRNA |
Compound |
Condition |
Effect |
Throughput |
PMID |
Details |
| miR-135b |
Erlotinib |
epithelial cancer(Non-small cell lung carcinoma (NSCLC) and pancreatic ductal adenocarcinoma (PDAC)) |
Resistant |
High |
22045191 |
|
| miR-135b |
Erlotinib |
pancreatic adenocarcinoma |
Sensitive |
High |
23918833 |
|
